Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$166,400
-$8,704 QoQ
Shares Held
17,835
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#311
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $4,377,396 across 7 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
63,441 | $2,149,381 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
5,428 | $914,835 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,019 | $552,124 | |
| 4 | ZTS |
Zoetis Inc.
|
6,658 | $478,443 | |
| 5 | HLN |
Haleon plc
This page
|
17,835 | $166,400 | |
| 6 | EVO |
Evotec SE
|
25,379 | $71,061 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
10,854 | $45,152 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $166,400 | 17,835 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $175,104 | 17,493 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $199,621 | 19,745 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $215,100 | 23,980 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $389,072 | 37,519 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $364,903 | 35,462 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $382,181 | 40,061 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $431,716 | 40,805 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $285,622 | 34,579 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $326,703 | 38,481 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $275,309 | 33,452 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $171,364 | 20,572 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $687,092 | 81,992 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $566,796 | 69,631 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $568,880 | 71,110 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $424,162 | 69,649 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||